These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1097 related items for PubMed ID: 26493305
1. Effects of catheter-based renal denervation on cardiac sympathetic activity and innervation in patients with resistant hypertension. Donazzan L, Mahfoud F, Ewen S, Ukena C, Cremers B, Kirsch CM, Hellwig D, Eweiwi T, Ezziddin S, Esler M, Böhm M. Clin Res Cardiol; 2016 Apr; 105(4):364-71. PubMed ID: 26493305 [Abstract] [Full Text] [Related]
2. Impact of renal sympathetic denervation on cardiac sympathetic nerve activity evaluated by cardiac MIBG imaging. Berukstis A, Vajauskas D, Gargalskaite U, Misonis N, Burneikaite G, Zakarkaite D, Miglinas M, Laucevicius A. EuroIntervention; 2016 Jan 22; 11(9):1070-6. PubMed ID: 26788709 [Abstract] [Full Text] [Related]
3. Atrial Remodeling Following Catheter-Based Renal Denervation Occurs in a Blood Pressure- and Heart Rate-Independent Manner. Schirmer SH, Sayed MM, Reil JC, Lavall D, Ukena C, Linz D, Mahfoud F, Böhm M. JACC Cardiovasc Interv; 2015 Jun 22; 8(7):972-80. PubMed ID: 26003031 [Abstract] [Full Text] [Related]
4. Effects of renal sympathetic denervation on cardiac sympathetic activity and function in patients with therapy resistant hypertension. van Brussel PM, Eeftinck Schattenkerk DW, Dobrowolski LC, de Winter RJ, Reekers JA, Verberne HJ, Vogt L, van den Born BJ. Int J Cardiol; 2016 Jan 01; 202():609-14. PubMed ID: 26447672 [Abstract] [Full Text] [Related]
5. Impact of renal denervation on tissue Na+ content in treatment-resistant hypertension. Ott C, Kopp C, Dahlmann A, Schmid A, Linz P, Cavallaro A, Hammon M, Ditting T, Veelken R, Uder M, Titze J, Schmieder RE. Clin Res Cardiol; 2018 Jan 01; 107(1):42-48. PubMed ID: 28845508 [Abstract] [Full Text] [Related]
6. Renal artery sympathetic denervation: observations from the UK experience. Sharp AS, Davies JE, Lobo MD, Bent CL, Mark PB, Burchell AE, Thackray SD, Martin U, McKane WS, Gerber RT, Wilkinson JR, Antonios TF, Doulton TW, Patterson T, Clifford PC, Lindsay A, Houston GJ, Freedman J, Das N, Belli AM, Faris M, Cleveland TJ, Nightingale AK, Hameed A, Mahadevan K, Finegold JA, Mather AN, Levy T, D'Souza R, Riley P, Moss JG, Di Mario C, Redwood SR, Baumbach A, Caulfield MJ, Dasgupta I. Clin Res Cardiol; 2016 Jun 01; 105(6):544-52. PubMed ID: 26802018 [Abstract] [Full Text] [Related]
7. Renal Sympathetic Denervation: A Viable Option for Treating Resistant Hypertension. Schlaich MP. Am J Hypertens; 2017 Sep 01; 30(9):847-856. PubMed ID: 28338871 [Abstract] [Full Text] [Related]
8. Safety and performance of the second generation EnligHTN™ Renal Denervation System in patients with drug-resistant, uncontrolled hypertension. Worthley SG, Wilkins GT, Webster MW, Montarello JK, Delacroix S, Whitbourn RJ, Warren RJ. Atherosclerosis; 2017 Jul 01; 262():94-100. PubMed ID: 28531827 [Abstract] [Full Text] [Related]